Contrast-enhanced subtraction harmonic sonography for evaluating treatment response in patients with hepatocellular carcinoma

American Journal of Roentgenology

Volumn 176, Issue 3, 2001, Pages 661-666

  Ding, H ^a   Kudo, M ^a   Onda, H ^a   Suetomi, Y ^a   Minami, Y ^a   Maekawa, K ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; EPIRUBICIN; ETHANOJECT; FARMORBICIN; IODINATED POPPYSEED OIL; SHU 508;

ACCURACY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; HUMAN; IMAGE SUBTRACTION; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; TUMOR NECROSIS; VASCULARIZATION;

EID: 0035115547     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/ajr.176.3.1760661     Document Type: Article

References (28)

1. Percutaneous ablation therapy for hepatocellular carcinomas
2. Hepatocellular carcinoma: Treatment with a combination therapy of transcatheter arterial embolization and percutaneous ethanol injection
3. Hepatocellular carcinoma: Treatment with percutaneous ethanol injection and transcatheter arterial embolization
4. Hepatocellular carcinoma: CT and MR features after transcatheter arterial embolization and percutaneous ethanol injection
5. Treatment of hepatocellular carcinoma: Value of percutaneous microwave coagulation
6. Ablation of liver tumors using percutaneous RF therapy
7. Monitoring treatment response with color and power Doppler
8. Color Doppler sonography of hepatocellular carcinoma before and after treatment by transcatheter arterial embolization
9. Hepatocellular carcinoma: Use of color Doppler US to evaluate response to treatment with percutaneous ethanol injection
10. Power Doppler sonography assessment of tumor recurrence after chemoembolization therapy for hepatocellular carcinoma
11. Small hepatocellular carcinoma: Differentiation from adenomatous hyperplastic nodule with color Doppler flow imaging
12. Visualization of tumor vessels in hepatocellular carcinoma
13. Contrast agents in diagnostic ultrasound
14. Color Doppler ultrasound of liver lesions: Signal enhancement after intravenous injection of the ultrasound contrast agent Levovist
15. Hepatocellular carcinoma: Power Doppler US with a contrast agent - Preliminary results
16. Improved sensitivity of colour Doppler flow imaging of colorectal hepatic metastases using galactose microparticles: A preliminary report
17. Harmonic imaging with ultrasound contrast agents
18. Harmonic hepatic US with microbubble contrast agent: Initial experience showing improved characterization of hemangioma, hepatocellular carcinoma, and metastasis
19. Vascularity of hepatocellular carcinoma: Assessment with contrast-enhanced second-harmonic versus conventional power Doppler US
20. Analysis of flash echo from contrast agent for designing optimal ultrasound diagnostic systems
21. Therapeutic effect of transcatheter oily chemoembolization therapy for encapsulated nodular hepatocellular carcinoma: CT and pathologic findings
22. Transcatheter chemoembolization effective for treating hepatocellular carcinoma: A histopathologic study
23. Radio-frequency-induced coagulation necrosis in rabbits: Immediate detection at US with a synthetic microsphere contrast agent
24. Percutaneous US-guided radio-frequency tissue ablation of liver metastases: Treatment and follow-up in 16 patients
25. Gray-scale second harmonic imaging of the fiver with galactose-based microbubbles
26. Evaluation of myocardial, hepatic, and renal perfusion in a variety of clinical conditions using an intravenous ultrasound contrast agent (Optison) and second harmonic imaging
27. Hepatocellular carcinoma treatment with percutaneous ethanol injection: Evaluation with contrast-enhanced color Doppler US
28. Radio-frequency ablation of hepatic metastases: Postprocedural assessment with a US microbubble contrast agent - Early experience